Dear online network
You may have seen some media recently about the Government's proposed changes to funding for bulk-billing of pathology and diagnostic imaging services, such as blood tests and mammograms.
BCNA is concerned about the impact that this may have as it could add to the mounting out-of-pocket costs we know women with breast cancer already face.
If the Senate agrees to the changes, incentives that are paid to health providers to bulk-bill pathology and diagnostic imaging services will be cut. This means that those who have been previously bulk-billed may face paying gap fee by their service provider which will not be refundable by Medicare.
We have put a response from BCNA on our homepage (link here) and will continue to monitor the outcome of these changes with the view that Australians diagnosed with breast cancer have access to affordable treatment and care.
Please feel free to contact policy@bcna.org.au if you have any queries.
Best
Eliisa
